A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RCOR1
|
ENSG00000089902.8 | REST corepressor 1 |
MTA3
|
ENSG00000057935.9 | metastasis associated 1 family member 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MTA3 | hg19_v2_chr2_+_42795745_42795824 | 0.63 | 1.8e-01 | Click! |
RCOR1 | hg19_v2_chr14_+_103058948_103059005 | -0.08 | 8.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_948803 | 7.89 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr11_-_615570 | 7.38 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr11_-_615942 | 6.37 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr17_-_72968837 | 5.86 |
ENST00000581676.1
|
HID1
|
HID1 domain containing |
chr19_+_15783879 | 5.63 |
ENST00000551607.1
|
CYP4F12
|
cytochrome P450, family 4, subfamily F, polypeptide 12 |
chr12_+_112451222 | 4.98 |
ENST00000552052.1
|
ERP29
|
endoplasmic reticulum protein 29 |
chr21_+_38338737 | 4.84 |
ENST00000430068.1
|
AP000704.5
|
AP000704.5 |
chr4_+_89299994 | 4.81 |
ENST00000264346.7
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr6_+_80714332 | 4.65 |
ENST00000502580.1
ENST00000511260.1 |
TTK
|
TTK protein kinase |
chr9_+_96717821 | 4.65 |
ENST00000454594.1
|
RP11-231K24.2
|
RP11-231K24.2 |
chrX_-_135056106 | 4.54 |
ENST00000433339.2
|
MMGT1
|
membrane magnesium transporter 1 |
chr20_-_62203808 | 4.36 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
chr12_-_104531785 | 4.13 |
ENST00000551727.1
|
NFYB
|
nuclear transcription factor Y, beta |
chr14_+_24630465 | 4.10 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr14_+_52781079 | 4.03 |
ENST00000245457.5
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa |
chr1_+_111682058 | 4.01 |
ENST00000545121.1
|
CEPT1
|
choline/ethanolamine phosphotransferase 1 |
chr19_-_48673465 | 3.94 |
ENST00000598938.1
|
LIG1
|
ligase I, DNA, ATP-dependent |
chr2_+_112813134 | 3.92 |
ENST00000452614.1
|
TMEM87B
|
transmembrane protein 87B |
chr3_-_122283079 | 3.70 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr12_-_121476959 | 3.62 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr3_-_122283424 | 3.60 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr10_+_91152303 | 3.57 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr4_+_89299885 | 3.56 |
ENST00000380265.5
ENST00000273960.3 |
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
chr8_+_26149007 | 3.53 |
ENST00000380737.3
ENST00000524169.1 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr1_+_111682827 | 3.53 |
ENST00000357172.4
|
CEPT1
|
choline/ethanolamine phosphotransferase 1 |
chr3_+_45730829 | 3.36 |
ENST00000438671.1
|
SACM1L
|
SAC1 suppressor of actin mutations 1-like (yeast) |
chr8_-_145060593 | 3.28 |
ENST00000313059.5
ENST00000524918.1 ENST00000313028.7 ENST00000525773.1 |
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chr21_+_42792442 | 3.23 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr7_-_105925558 | 3.18 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr2_+_46926326 | 3.15 |
ENST00000394861.2
|
SOCS5
|
suppressor of cytokine signaling 5 |
chr4_-_56412713 | 3.14 |
ENST00000435527.2
|
CLOCK
|
clock circadian regulator |
chr11_-_96123022 | 3.14 |
ENST00000542662.1
|
CCDC82
|
coiled-coil domain containing 82 |
chr12_-_121477039 | 3.13 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr19_+_50031547 | 3.11 |
ENST00000597801.1
|
RCN3
|
reticulocalbin 3, EF-hand calcium binding domain |
chr3_-_122283100 | 3.05 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr1_+_65886244 | 3.05 |
ENST00000344610.8
|
LEPR
|
leptin receptor |
chr1_-_92764523 | 3.02 |
ENST00000370360.3
ENST00000534881.1 |
GLMN
|
glomulin, FKBP associated protein |
chr3_-_149688502 | 3.01 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
chr16_+_77246337 | 2.99 |
ENST00000563157.1
|
SYCE1L
|
synaptonemal complex central element protein 1-like |
chr1_+_33352036 | 2.98 |
ENST00000373467.3
|
HPCA
|
hippocalcin |
chr19_+_18077881 | 2.96 |
ENST00000609922.1
|
KCNN1
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 |
chr12_-_123459105 | 2.96 |
ENST00000543935.1
|
ABCB9
|
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
chr1_-_93426998 | 2.94 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
chr3_+_121554046 | 2.91 |
ENST00000273668.2
ENST00000451944.2 |
EAF2
|
ELL associated factor 2 |
chr1_-_86861660 | 2.91 |
ENST00000486215.1
|
ODF2L
|
outer dense fiber of sperm tails 2-like |
chr20_+_52824367 | 2.89 |
ENST00000371419.2
|
PFDN4
|
prefoldin subunit 4 |
chr1_+_25071848 | 2.85 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
chr21_+_42798094 | 2.84 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr2_-_74645669 | 2.84 |
ENST00000518401.1
|
C2orf81
|
chromosome 2 open reading frame 81 |
chr22_-_50970506 | 2.80 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr10_-_126849626 | 2.80 |
ENST00000530884.1
|
CTBP2
|
C-terminal binding protein 2 |
chr1_-_63988846 | 2.80 |
ENST00000283568.8
ENST00000371092.3 ENST00000271002.10 |
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin) |
chr3_-_113464906 | 2.78 |
ENST00000477813.1
|
NAA50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
chr1_+_65886326 | 2.78 |
ENST00000371059.3
ENST00000371060.3 ENST00000349533.6 ENST00000406510.3 |
LEPR
|
leptin receptor |
chr12_-_44152551 | 2.76 |
ENST00000416848.2
ENST00000550784.1 ENST00000547156.1 ENST00000549868.1 ENST00000553166.1 ENST00000551923.1 ENST00000431332.3 ENST00000344862.5 |
PUS7L
|
pseudouridylate synthase 7 homolog (S. cerevisiae)-like |
chr9_-_4741255 | 2.76 |
ENST00000381809.3
|
AK3
|
adenylate kinase 3 |
chr19_+_496454 | 2.75 |
ENST00000346144.4
ENST00000215637.3 ENST00000382683.4 |
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1 |
chr16_+_56691911 | 2.75 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
chr4_-_185570590 | 2.75 |
ENST00000517513.1
ENST00000447121.2 ENST00000393588.4 ENST00000308394.4 ENST00000523916.1 |
CASP3
|
caspase 3, apoptosis-related cysteine peptidase |
chr14_-_45603657 | 2.72 |
ENST00000396062.3
|
FKBP3
|
FK506 binding protein 3, 25kDa |
chr7_-_108209897 | 2.72 |
ENST00000313516.5
|
THAP5
|
THAP domain containing 5 |
chr20_-_58508702 | 2.71 |
ENST00000357552.3
ENST00000425931.1 |
SYCP2
|
synaptonemal complex protein 2 |
chr3_-_146262428 | 2.70 |
ENST00000486631.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr4_-_155533787 | 2.69 |
ENST00000407946.1
ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG
|
fibrinogen gamma chain |
chr12_-_76477707 | 2.69 |
ENST00000551992.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr12_-_76478386 | 2.67 |
ENST00000535020.2
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr13_-_52026730 | 2.66 |
ENST00000420668.2
|
INTS6
|
integrator complex subunit 6 |
chr4_+_164415785 | 2.65 |
ENST00000513272.1
ENST00000513134.1 |
TMA16
|
translation machinery associated 16 homolog (S. cerevisiae) |
chr9_-_33402506 | 2.64 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
chr11_-_17410869 | 2.64 |
ENST00000528731.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
chr12_+_72058130 | 2.64 |
ENST00000547843.1
|
THAP2
|
THAP domain containing, apoptosis associated protein 2 |
chr1_-_27998689 | 2.63 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr4_-_101111615 | 2.63 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
chr7_-_95225768 | 2.62 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
chr1_+_10057274 | 2.60 |
ENST00000294435.7
|
RBP7
|
retinol binding protein 7, cellular |
chr14_+_94577074 | 2.59 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr3_-_42845951 | 2.58 |
ENST00000418900.2
ENST00000430190.1 |
HIGD1A
|
HIG1 hypoxia inducible domain family, member 1A |
chr3_-_88108192 | 2.58 |
ENST00000309534.6
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
chr11_-_321050 | 2.57 |
ENST00000399808.4
|
IFITM3
|
interferon induced transmembrane protein 3 |
chr3_-_195163584 | 2.56 |
ENST00000439666.1
|
ACAP2
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 |
chr10_+_60145155 | 2.55 |
ENST00000373895.3
|
TFAM
|
transcription factor A, mitochondrial |
chr14_+_21492331 | 2.55 |
ENST00000533984.1
ENST00000532213.2 |
AL161668.5
|
AL161668.5 |
chr12_-_76478446 | 2.53 |
ENST00000393263.3
ENST00000548044.1 ENST00000547704.1 ENST00000431879.3 ENST00000549596.1 ENST00000550934.1 ENST00000551600.1 ENST00000547479.1 ENST00000547773.1 ENST00000544816.1 ENST00000542344.1 ENST00000548273.1 |
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chr16_+_56672571 | 2.52 |
ENST00000290705.8
|
MT1A
|
metallothionein 1A |
chr17_+_62075703 | 2.52 |
ENST00000577953.1
ENST00000582540.1 ENST00000579184.1 ENST00000425164.3 ENST00000412177.1 ENST00000539996.1 ENST00000583891.1 ENST00000580752.1 |
C17orf72
|
chromosome 17 open reading frame 72 |
chr4_+_164265035 | 2.51 |
ENST00000338566.3
|
NPY5R
|
neuropeptide Y receptor Y5 |
chr16_+_28857957 | 2.51 |
ENST00000567536.1
|
SH2B1
|
SH2B adaptor protein 1 |
chr15_-_35280426 | 2.51 |
ENST00000559564.1
ENST00000356321.4 |
ZNF770
|
zinc finger protein 770 |
chr6_+_80714318 | 2.50 |
ENST00000369798.2
|
TTK
|
TTK protein kinase |
chr1_-_193028426 | 2.50 |
ENST00000367450.3
ENST00000530098.2 ENST00000367451.4 ENST00000367448.1 ENST00000367449.1 |
UCHL5
|
ubiquitin carboxyl-terminal hydrolase L5 |
chr7_+_77167343 | 2.49 |
ENST00000433369.2
ENST00000415482.2 |
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr3_+_23847432 | 2.48 |
ENST00000346855.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
chr1_+_44401479 | 2.48 |
ENST00000438616.3
|
ARTN
|
artemin |
chr11_+_61583968 | 2.48 |
ENST00000517839.1
|
FADS2
|
fatty acid desaturase 2 |
chr22_-_50970566 | 2.47 |
ENST00000405135.1
ENST00000401779.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr8_-_52811564 | 2.47 |
ENST00000522514.1
|
PCMTD1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 |
chr1_-_229406746 | 2.45 |
ENST00000429227.1
ENST00000436334.1 |
RP5-1061H20.4
|
RP5-1061H20.4 |
chr3_+_73045936 | 2.45 |
ENST00000356692.5
ENST00000488810.1 ENST00000394284.3 ENST00000295862.9 ENST00000495566.1 |
PPP4R2
|
protein phosphatase 4, regulatory subunit 2 |
chr9_+_37120536 | 2.45 |
ENST00000336755.5
ENST00000534928.1 ENST00000322831.6 |
ZCCHC7
|
zinc finger, CCHC domain containing 7 |
chrX_+_154444643 | 2.44 |
ENST00000286428.5
|
VBP1
|
von Hippel-Lindau binding protein 1 |
chr1_-_111682662 | 2.43 |
ENST00000286692.4
|
DRAM2
|
DNA-damage regulated autophagy modulator 2 |
chr11_+_77532233 | 2.42 |
ENST00000525409.1
|
AAMDC
|
adipogenesis associated, Mth938 domain containing |
chr4_-_1107306 | 2.42 |
ENST00000433731.2
ENST00000333673.5 ENST00000382968.5 |
RNF212
|
ring finger protein 212 |
chr2_-_197791441 | 2.40 |
ENST00000409475.1
ENST00000354764.4 ENST00000374738.3 |
PGAP1
|
post-GPI attachment to proteins 1 |
chr4_+_71859156 | 2.39 |
ENST00000286648.5
ENST00000504730.1 ENST00000504952.1 |
DCK
|
deoxycytidine kinase |
chr3_-_71802760 | 2.39 |
ENST00000295612.3
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
chr5_+_61602236 | 2.38 |
ENST00000514082.1
ENST00000407818.3 |
KIF2A
|
kinesin heavy chain member 2A |
chr2_-_38604398 | 2.37 |
ENST00000443098.1
ENST00000449130.1 ENST00000378954.4 ENST00000539122.1 ENST00000419554.2 ENST00000451483.1 ENST00000406122.1 |
ATL2
|
atlastin GTPase 2 |
chr1_+_16084428 | 2.37 |
ENST00000510929.1
ENST00000502638.1 |
FBLIM1
|
filamin binding LIM protein 1 |
chr2_-_120124258 | 2.33 |
ENST00000409877.1
ENST00000409523.1 ENST00000409466.2 ENST00000414534.1 |
C2orf76
|
chromosome 2 open reading frame 76 |
chr11_+_76571911 | 2.33 |
ENST00000534206.1
ENST00000532485.1 ENST00000526597.1 ENST00000533873.1 ENST00000538157.1 |
ACER3
|
alkaline ceramidase 3 |
chr1_-_111682813 | 2.32 |
ENST00000539140.1
|
DRAM2
|
DNA-damage regulated autophagy modulator 2 |
chr1_+_45140400 | 2.32 |
ENST00000453711.1
|
C1orf228
|
chromosome 1 open reading frame 228 |
chr6_-_110500905 | 2.32 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
chr2_+_9563769 | 2.30 |
ENST00000475482.1
|
CPSF3
|
cleavage and polyadenylation specific factor 3, 73kDa |
chr11_-_64512273 | 2.30 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr14_+_64970427 | 2.30 |
ENST00000553583.1
|
ZBTB1
|
zinc finger and BTB domain containing 1 |
chr3_-_170626376 | 2.29 |
ENST00000487522.1
ENST00000474417.1 |
EIF5A2
|
eukaryotic translation initiation factor 5A2 |
chr13_-_52027134 | 2.29 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
chr9_+_79792269 | 2.28 |
ENST00000376634.4
ENST00000376636.3 ENST00000360280.3 |
VPS13A
|
vacuolar protein sorting 13 homolog A (S. cerevisiae) |
chr14_+_24641062 | 2.27 |
ENST00000311457.3
ENST00000557806.1 ENST00000559919.1 |
REC8
|
REC8 meiotic recombination protein |
chr3_+_167453493 | 2.27 |
ENST00000295777.5
ENST00000472747.2 |
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
chr16_-_30596818 | 2.27 |
ENST00000567773.1
|
ZNF785
|
zinc finger protein 785 |
chr3_-_146262365 | 2.25 |
ENST00000448787.2
|
PLSCR1
|
phospholipid scramblase 1 |
chr7_-_151137094 | 2.24 |
ENST00000491928.1
ENST00000337323.2 |
CRYGN
|
crystallin, gamma N |
chr2_+_163200848 | 2.24 |
ENST00000233612.4
|
GCA
|
grancalcin, EF-hand calcium binding protein |
chr3_-_185542817 | 2.24 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr2_+_201390843 | 2.24 |
ENST00000357799.4
ENST00000409203.3 |
SGOL2
|
shugoshin-like 2 (S. pombe) |
chr12_-_7245018 | 2.24 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr14_+_52780998 | 2.23 |
ENST00000557436.1
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa |
chr19_+_21203426 | 2.23 |
ENST00000261560.5
ENST00000599548.1 ENST00000594110.1 |
ZNF430
|
zinc finger protein 430 |
chr11_+_105948216 | 2.23 |
ENST00000278618.4
|
AASDHPPT
|
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase |
chr14_-_62162541 | 2.22 |
ENST00000557544.1
|
HIF1A-AS1
|
HIF1A antisense RNA 1 |
chr16_+_56691838 | 2.22 |
ENST00000394501.2
|
MT1F
|
metallothionein 1F |
chr17_+_45771420 | 2.22 |
ENST00000578982.1
|
TBKBP1
|
TBK1 binding protein 1 |
chr2_+_46926048 | 2.22 |
ENST00000306503.5
|
SOCS5
|
suppressor of cytokine signaling 5 |
chr1_+_78354175 | 2.21 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
chr1_-_115632035 | 2.21 |
ENST00000433172.1
ENST00000369514.2 ENST00000369516.2 ENST00000369515.2 |
TSPAN2
|
tetraspanin 2 |
chr7_+_77167376 | 2.21 |
ENST00000435495.2
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr10_+_131934643 | 2.20 |
ENST00000331244.5
ENST00000368644.1 |
GLRX3
|
glutaredoxin 3 |
chr11_+_46402482 | 2.20 |
ENST00000441869.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr3_+_49044765 | 2.19 |
ENST00000429900.2
|
WDR6
|
WD repeat domain 6 |
chr7_-_149470297 | 2.18 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
chr4_+_17579110 | 2.17 |
ENST00000606142.1
|
LAP3
|
leucine aminopeptidase 3 |
chr9_-_15307200 | 2.17 |
ENST00000506891.1
ENST00000541445.1 ENST00000512701.2 ENST00000380850.4 ENST00000297615.5 ENST00000355694.2 |
TTC39B
|
tetratricopeptide repeat domain 39B |
chr6_+_13925098 | 2.17 |
ENST00000488300.1
ENST00000544682.1 ENST00000420478.2 |
RNF182
|
ring finger protein 182 |
chr14_-_35183755 | 2.17 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
chr7_-_100823496 | 2.17 |
ENST00000455377.1
ENST00000443096.1 ENST00000300303.2 |
NAT16
|
N-acetyltransferase 16 (GCN5-related, putative) |
chr15_-_45459704 | 2.15 |
ENST00000558039.1
|
CTD-2651B20.1
|
CTD-2651B20.1 |
chr7_+_7222233 | 2.15 |
ENST00000436587.2
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
chr19_+_57050317 | 2.14 |
ENST00000301318.3
ENST00000591844.1 |
ZFP28
|
ZFP28 zinc finger protein |
chr6_+_139349903 | 2.14 |
ENST00000461027.1
|
ABRACL
|
ABRA C-terminal like |
chr11_-_790060 | 2.14 |
ENST00000330106.4
|
CEND1
|
cell cycle exit and neuronal differentiation 1 |
chr17_-_53499310 | 2.14 |
ENST00000262065.3
|
MMD
|
monocyte to macrophage differentiation-associated |
chr1_+_62901968 | 2.13 |
ENST00000452143.1
ENST00000442679.1 ENST00000371146.1 |
USP1
|
ubiquitin specific peptidase 1 |
chr9_-_113018746 | 2.13 |
ENST00000374515.5
|
TXN
|
thioredoxin |
chr7_-_105925367 | 2.13 |
ENST00000354289.4
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr6_-_109703663 | 2.12 |
ENST00000368961.5
|
CD164
|
CD164 molecule, sialomucin |
chr9_+_129987488 | 2.12 |
ENST00000446764.1
|
GARNL3
|
GTPase activating Rap/RanGAP domain-like 3 |
chr4_+_52709229 | 2.12 |
ENST00000334635.5
ENST00000381441.3 ENST00000381437.4 |
DCUN1D4
|
DCN1, defective in cullin neddylation 1, domain containing 4 |
chr3_-_132441209 | 2.12 |
ENST00000383282.2
ENST00000326682.8 ENST00000343113.4 ENST00000337331.5 |
NPHP3
|
nephronophthisis 3 (adolescent) |
chr19_+_55795493 | 2.12 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr1_+_40723779 | 2.11 |
ENST00000372759.3
|
ZMPSTE24
|
zinc metallopeptidase STE24 |
chr11_-_65363259 | 2.11 |
ENST00000342202.4
|
KCNK7
|
potassium channel, subfamily K, member 7 |
chr4_+_25378826 | 2.11 |
ENST00000315368.3
|
ANAPC4
|
anaphase promoting complex subunit 4 |
chr1_-_85156417 | 2.10 |
ENST00000422026.1
|
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein |
chr1_-_68962744 | 2.10 |
ENST00000525124.1
|
DEPDC1
|
DEP domain containing 1 |
chr11_+_22214708 | 2.10 |
ENST00000324559.8
|
ANO5
|
anoctamin 5 |
chr10_+_124739964 | 2.10 |
ENST00000406217.2
|
PSTK
|
phosphoseryl-tRNA kinase |
chr19_-_9879293 | 2.10 |
ENST00000397902.2
ENST00000592859.1 ENST00000588267.1 |
ZNF846
|
zinc finger protein 846 |
chr3_-_112738490 | 2.09 |
ENST00000393857.2
|
C3orf17
|
chromosome 3 open reading frame 17 |
chr8_+_110551925 | 2.09 |
ENST00000395785.2
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9 |
chr8_-_25315905 | 2.09 |
ENST00000221200.4
|
KCTD9
|
potassium channel tetramerization domain containing 9 |
chr2_-_179315786 | 2.08 |
ENST00000457633.1
ENST00000438687.3 ENST00000325748.4 |
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator |
chr13_-_20437648 | 2.07 |
ENST00000382907.4
ENST00000382905.4 |
ZMYM5
|
zinc finger, MYM-type 5 |
chr8_-_90996459 | 2.07 |
ENST00000517337.1
ENST00000409330.1 |
NBN
|
nibrin |
chr17_+_41177220 | 2.06 |
ENST00000587250.2
ENST00000544533.1 |
RND2
|
Rho family GTPase 2 |
chr4_-_104119528 | 2.06 |
ENST00000380026.3
ENST00000503705.1 ENST00000265148.3 |
CENPE
|
centromere protein E, 312kDa |
chr19_+_10197463 | 2.05 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr4_-_169239921 | 2.05 |
ENST00000514995.1
ENST00000393743.3 |
DDX60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr7_+_33945132 | 2.05 |
ENST00000436222.1
|
BMPER
|
BMP binding endothelial regulator |
chr2_-_27938593 | 2.05 |
ENST00000379677.2
|
AC074091.13
|
Uncharacterized protein |
chr2_+_162101247 | 2.04 |
ENST00000439050.1
ENST00000436506.1 |
AC009299.3
|
AC009299.3 |
chr4_-_4291761 | 2.04 |
ENST00000513174.1
|
LYAR
|
Ly1 antibody reactive |
chr8_+_104152922 | 2.04 |
ENST00000309982.5
ENST00000438105.2 ENST00000297574.6 |
BAALC
|
brain and acute leukemia, cytoplasmic |
chr1_+_92495528 | 2.04 |
ENST00000370383.4
|
EPHX4
|
epoxide hydrolase 4 |
chr9_+_79792410 | 2.03 |
ENST00000357409.5
|
VPS13A
|
vacuolar protein sorting 13 homolog A (S. cerevisiae) |
chr10_+_103986085 | 2.03 |
ENST00000370005.3
|
ELOVL3
|
ELOVL fatty acid elongase 3 |
chr1_-_1850697 | 2.02 |
ENST00000378598.4
ENST00000416272.1 ENST00000310991.3 |
TMEM52
|
transmembrane protein 52 |
chr8_-_97273807 | 2.02 |
ENST00000517720.1
ENST00000287025.3 ENST00000523821.1 |
MTERFD1
|
MTERF domain containing 1 |
chr4_+_185570767 | 2.02 |
ENST00000314970.6
ENST00000515774.1 ENST00000503752.1 |
PRIMPOL
|
primase and polymerase (DNA-directed) |
chr12_-_7245080 | 2.02 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
chr7_-_112579673 | 2.01 |
ENST00000432572.1
|
C7orf60
|
chromosome 7 open reading frame 60 |
chr22_+_24577183 | 2.01 |
ENST00000358321.3
|
SUSD2
|
sushi domain containing 2 |
chr14_+_45553296 | 2.01 |
ENST00000355765.6
ENST00000553605.1 |
PRPF39
|
pre-mRNA processing factor 39 |
chr17_+_2264983 | 2.01 |
ENST00000574650.1
|
SGSM2
|
small G protein signaling modulator 2 |
chr4_-_83483360 | 2.00 |
ENST00000449862.2
|
TMEM150C
|
transmembrane protein 150C |
chr4_-_74864386 | 2.00 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr3_-_185542761 | 1.99 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr6_+_12008986 | 1.99 |
ENST00000491710.1
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.9 | 7.4 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
1.6 | 4.9 | GO:0003095 | pressure natriuresis(GO:0003095) |
1.5 | 7.5 | GO:0043335 | protein unfolding(GO:0043335) |
1.4 | 16.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.3 | 14.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.3 | 2.6 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.3 | 12.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.3 | 3.8 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
1.3 | 3.8 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
1.2 | 1.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
1.2 | 4.8 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
1.2 | 3.5 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
1.2 | 4.7 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
1.1 | 1.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
1.1 | 3.3 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
1.1 | 1.1 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
1.0 | 3.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.0 | 3.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.0 | 5.1 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
1.0 | 6.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.0 | 1.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 1.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.0 | 5.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.0 | 2.9 | GO:0060733 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
1.0 | 1.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
1.0 | 5.8 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.9 | 0.9 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.9 | 4.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.9 | 3.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.9 | 3.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.9 | 3.6 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.9 | 2.7 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.9 | 0.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.9 | 0.9 | GO:0030814 | regulation of cAMP metabolic process(GO:0030814) regulation of cAMP biosynthetic process(GO:0030817) |
0.9 | 2.6 | GO:0042938 | dipeptide transport(GO:0042938) |
0.9 | 2.6 | GO:0045360 | interleukin-1 biosynthetic process(GO:0042222) regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.9 | 0.9 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.9 | 1.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.8 | 0.8 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.8 | 7.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.8 | 5.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 3.3 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.8 | 2.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.8 | 1.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.8 | 1.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.8 | 3.2 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.8 | 0.8 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.8 | 1.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
0.8 | 3.9 | GO:0006311 | meiotic gene conversion(GO:0006311) |
0.8 | 5.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.8 | 3.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.8 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.8 | 2.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.8 | 5.4 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.8 | 0.8 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.8 | 3.1 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
0.8 | 1.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.7 | 2.2 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.7 | 3.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.7 | 3.0 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) negative regulation of apoptotic cell clearance(GO:2000426) |
0.7 | 2.2 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.7 | 2.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.7 | 2.2 | GO:0071789 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.7 | 3.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.7 | 2.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.7 | 0.7 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.7 | 2.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.7 | 0.7 | GO:0032535 | regulation of cellular component size(GO:0032535) |
0.7 | 2.8 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.7 | 4.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.7 | 8.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.7 | 0.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.7 | 2.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.7 | 0.7 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.7 | 2.1 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.7 | 6.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.7 | 2.1 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.7 | 3.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.7 | 4.1 | GO:0030421 | defecation(GO:0030421) |
0.7 | 8.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 12.7 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.7 | 4.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.7 | 2.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.7 | 0.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.7 | 2.0 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.6 | 0.6 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.6 | 3.9 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.6 | 1.9 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.6 | 1.9 | GO:0000921 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
0.6 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.6 | 3.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.6 | 7.6 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 1.9 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
0.6 | 1.9 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.6 | 5.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 3.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.6 | 0.6 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.6 | 3.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.6 | 1.9 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.6 | 3.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.6 | 1.8 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
0.6 | 1.8 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 2.4 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.6 | 6.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.6 | 2.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.6 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.6 | 5.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.6 | 1.8 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.6 | 5.9 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.6 | 1.8 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.6 | 1.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.6 | 0.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.6 | 1.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.6 | 6.4 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 0.6 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 2.3 | GO:0051836 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.6 | 1.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.6 | 1.1 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.6 | 2.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.6 | 0.6 | GO:0015732 | prostaglandin transport(GO:0015732) prostaglandin secretion(GO:0032310) |
0.6 | 1.7 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.6 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.6 | 2.8 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.6 | 2.8 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.6 | 1.7 | GO:0007135 | meiosis II(GO:0007135) |
0.6 | 2.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.6 | 2.2 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.6 | 1.7 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.6 | 2.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.6 | 0.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 2.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.6 | 3.9 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.6 | 0.6 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.6 | 1.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.6 | 1.1 | GO:0002699 | positive regulation of immune effector process(GO:0002699) |
0.5 | 1.6 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.5 | 3.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.5 | 4.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.5 | 3.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 7.0 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 6.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.5 | 1.6 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.5 | 1.6 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.5 | 1.6 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.5 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.5 | 2.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 4.3 | GO:0015793 | glycerol transport(GO:0015793) |
0.5 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.5 | 1.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.5 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 1.6 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.5 | 3.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.5 | 1.0 | GO:0036292 | DNA rewinding(GO:0036292) |
0.5 | 1.6 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.5 | 5.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.5 | 1.0 | GO:0045579 | regulation of B cell differentiation(GO:0045577) positive regulation of B cell differentiation(GO:0045579) |
0.5 | 1.5 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.5 | 1.5 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.5 | 1.0 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.5 | 2.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 4.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.5 | 0.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.5 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 6.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.5 | 1.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.5 | 1.5 | GO:0019516 | lactate oxidation(GO:0019516) |
0.5 | 1.5 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.5 | 2.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 0.5 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.5 | 4.0 | GO:1901189 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.5 | 1.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.5 | 4.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 0.5 | GO:1901295 | regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.5 | 2.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 5.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.5 | 2.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 0.5 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.5 | 5.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 1.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 1.0 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.5 | 2.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 3.4 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.5 | 3.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 2.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 1.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 2.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.5 | 1.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.5 | 1.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.5 | 0.5 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.5 | 1.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 0.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.5 | 14.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 1.9 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.5 | 2.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.5 | 1.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 2.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.5 | 1.4 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.5 | 1.4 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.5 | 0.5 | GO:0048565 | digestive tract development(GO:0048565) |
0.5 | 4.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.5 | 1.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 0.5 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.5 | 0.9 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.5 | 1.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.5 | 7.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 0.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.5 | 0.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.5 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 0.5 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.5 | 2.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.5 | 4.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 3.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 2.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.5 | 1.4 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.4 | 1.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 2.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.4 | 1.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.4 | 0.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 5.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.4 | 0.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.4 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 0.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.4 | 2.7 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.4 | 1.8 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.4 | 0.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
0.4 | 0.9 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.4 | 1.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 2.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.4 | 1.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.4 | 1.7 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.4 | 3.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 1.3 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.4 | 6.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.4 | 1.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.4 | 1.3 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.4 | 3.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 0.4 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.4 | 2.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.4 | 1.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 2.6 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.4 | 2.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.4 | 1.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.3 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.4 | 3.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.4 | 1.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.4 | 2.1 | GO:0001878 | response to yeast(GO:0001878) |
0.4 | 2.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 0.9 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 2.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 0.8 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.4 | 3.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.4 | 0.8 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
0.4 | 2.1 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.4 | 1.7 | GO:0070647 | protein modification by small protein conjugation(GO:0032446) protein modification by small protein conjugation or removal(GO:0070647) |
0.4 | 1.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.4 | 4.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.4 | 1.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.4 | 2.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 2.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 0.4 | GO:0097009 | energy homeostasis(GO:0097009) |
0.4 | 3.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.4 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 1.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.4 | 2.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.4 | 3.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 1.2 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.4 | 1.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 3.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.4 | 2.0 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.4 | 2.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 1.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.4 | 1.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 2.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 1.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.4 | 2.8 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 2.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.4 | 1.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.4 | 0.8 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.4 | 0.8 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
0.4 | 3.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.4 | 6.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 2.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 0.8 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.4 | 8.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 2.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 6.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 0.8 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.4 | 2.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.4 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 0.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 2.0 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.4 | 4.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 1.9 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.4 | 2.3 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 1.2 | GO:0006272 | leading strand elongation(GO:0006272) |
0.4 | 1.5 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.4 | 3.9 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.4 | 1.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 3.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 5.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 1.5 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.4 | 0.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 1.1 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.4 | 1.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 4.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 4.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 1.5 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.4 | 0.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 0.4 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.4 | 1.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.4 | 4.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 1.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 0.7 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.4 | 1.5 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.4 | 1.5 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.4 | 7.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 1.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.4 | 3.3 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 0.4 | GO:0050881 | skeletal muscle contraction(GO:0003009) multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.4 | 0.7 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.4 | 1.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.4 | 5.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.4 | 1.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.4 | 1.1 | GO:1903515 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.4 | 0.7 | GO:0014877 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 1.4 | GO:1904448 | gamma-aminobutyric acid biosynthetic process(GO:0009449) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.4 | 0.7 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.4 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 2.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 1.8 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.4 | 0.4 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.4 | 1.8 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.4 | 2.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 1.1 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.4 | 4.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.4 | 2.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.4 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 2.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 2.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.4 | 1.1 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.4 | 0.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.4 | 1.8 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.4 | 1.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 13.8 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.4 | 2.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.4 | 1.4 | GO:2000230 | regulation of cholesterol transporter activity(GO:0060694) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.4 | 4.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 2.8 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 2.8 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 3.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 3.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 1.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 0.3 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.3 | 2.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 1.0 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.3 | 2.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 1.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 1.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 3.1 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.3 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.3 | 1.0 | GO:2000340 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.3 | 7.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 0.3 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) protein targeting to vacuole involved in autophagy(GO:0071211) |
0.3 | 1.7 | GO:0010157 | response to chlorate(GO:0010157) |
0.3 | 1.0 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.3 | 1.0 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 14.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 4.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 0.3 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.3 | 1.0 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.3 | 3.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 7.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 3.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.3 | 0.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.3 | 1.3 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.3 | 1.7 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.3 | 2.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 0.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 6.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 0.3 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 4.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 0.7 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 3.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.7 | GO:0072078 | ureteric bud morphogenesis(GO:0060675) nephron tubule morphogenesis(GO:0072078) |
0.3 | 4.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 1.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 2.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.3 | 3.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 1.6 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.3 | 4.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.3 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 1.0 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 2.5 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.3 | 2.8 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.3 | 1.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.3 | 0.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.3 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 1.6 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 1.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.3 | 0.9 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.3 | 0.9 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.3 | 1.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.3 | 1.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 0.9 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.3 | 1.2 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.3 | 1.5 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 2.2 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.3 | 1.2 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.3 | 0.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 1.8 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 1.5 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.3 | 0.3 | GO:0015880 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.3 | 0.6 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.3 | 0.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 1.8 | GO:1990523 | bone regeneration(GO:1990523) |
0.3 | 1.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.3 | 0.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.3 | 4.2 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 1.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 4.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.3 | 8.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 0.3 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
0.3 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 1.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.3 | 4.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 0.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 0.9 | GO:0002188 | translation reinitiation(GO:0002188) |
0.3 | 1.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 1.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.9 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.3 | 1.5 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.3 | 0.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.3 | 4.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.3 | 1.2 | GO:0048489 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.3 | 1.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.3 | 1.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.3 | 1.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 4.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.3 | 2.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.9 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.3 | 4.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 1.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 1.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.3 | 17.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 6.4 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.3 | 7.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.3 | 1.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.3 | 1.7 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.3 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.3 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 2.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 1.1 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.3 | 7.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 5.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 0.3 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.3 | 2.9 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 1.4 | GO:0006833 | water transport(GO:0006833) |
0.3 | 1.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.9 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 15.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.3 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.3 | 1.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.3 | 1.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.3 | 4.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 18.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 0.3 | GO:1903532 | positive regulation of secretion by cell(GO:1903532) |
0.3 | 0.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.3 | 0.8 | GO:0050894 | determination of affect(GO:0050894) |
0.3 | 0.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.7 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.3 | 0.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.3 | 4.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 0.3 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.3 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 0.6 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.3 | 1.9 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.3 | 0.3 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.3 | 0.8 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.3 | 2.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 1.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.3 | 1.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 2.4 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 0.5 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.3 | 1.9 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 3.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.3 | 1.1 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.3 | 5.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.3 | 0.3 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.4 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.3 | 0.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 1.1 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.3 | 0.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 2.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.3 | 1.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 8.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.3 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.3 | 0.5 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.3 | 0.8 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.3 | 0.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 0.8 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.3 | 0.8 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.3 | 2.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.3 | 0.8 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.3 | 0.5 | GO:0009386 | translational attenuation(GO:0009386) |
0.3 | 8.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 1.6 | GO:0070265 | necrotic cell death(GO:0070265) |
0.3 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 1.3 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.3 | 1.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.3 | 3.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 0.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.3 | 0.8 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 2.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.3 | 1.5 | GO:0050900 | leukocyte migration(GO:0050900) |
0.3 | 0.5 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.3 | 0.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 0.5 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.3 | 0.5 | GO:1904204 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.3 | 1.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.3 | 1.5 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 1.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.3 | 2.3 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.3 | 3.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 6.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 1.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.3 | 1.0 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.3 | 0.3 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.3 | 1.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.3 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 1.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 2.8 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.3 | 0.5 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.2 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.7 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.2 | 1.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.2 | 1.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 3.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 3.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.5 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 3.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.2 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 1.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 3.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 1.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 1.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.5 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.7 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.2 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 4.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 1.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 1.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 2.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 2.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 1.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.7 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 1.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 0.7 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.2 | 0.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 1.9 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.2 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 1.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 4.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.7 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.2 | 0.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 0.5 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.2 | 0.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 2.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.2 | 1.8 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 1.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 2.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 1.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 2.0 | GO:0045213 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.7 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.9 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.2 | 0.7 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.2 | 0.9 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.2 | 3.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 | 2.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 0.9 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 4.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.4 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.2 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.7 | GO:0046056 | dADP metabolic process(GO:0046056) |
0.2 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.2 | 0.7 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.2 | 3.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 2.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 2.9 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 1.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.2 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.2 | 0.2 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
0.2 | 0.7 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.2 | 2.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.9 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 0.2 | GO:0009206 | purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.2 | 2.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.3 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.2 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.2 | 7.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 2.0 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.2 | 0.9 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 0.7 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.2 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.2 | 0.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 0.4 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.2 | 1.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 2.2 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 3.2 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
0.2 | 1.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 3.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 0.9 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.2 | 0.6 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.2 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 5.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.2 | 3.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.2 | 1.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.6 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.2 | 0.8 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.2 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 1.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 0.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.8 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.2 | 1.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.4 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.2 | 2.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.8 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.2 | 1.7 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.4 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 1.2 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.2 | 2.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 1.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.2 | 0.2 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.2 | 1.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.2 | 2.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 2.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 0.6 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.2 | 1.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 1.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.2 | 0.4 | GO:1902739 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.2 | 0.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.2 | 0.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 1.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 1.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 2.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 7.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 1.8 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 0.6 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.2 | 3.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 1.0 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.2 | 0.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 0.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.6 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.8 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.2 | 0.8 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 1.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 0.6 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.2 | 0.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.2 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.2 | 7.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.0 | GO:1903278 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 2.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.6 | GO:0090195 | chemokine secretion(GO:0090195) |
0.2 | 4.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 2.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 1.3 | GO:0090279 | regulation of calcium ion import(GO:0090279) |
0.2 | 0.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.2 | 0.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.2 | 2.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.4 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.2 | 2.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 5.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 1.1 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.2 | 0.2 | GO:0021590 | hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.2 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 4.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.8 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.2 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.2 | 0.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.2 | 0.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.2 | 0.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 6.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 2.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 3.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 3.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.6 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 1.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.5 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.2 | 0.9 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.8 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.7 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.2 | 0.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.2 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.2 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.7 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.2 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 5.4 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 1.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 1.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 2.3 | GO:0042755 | eating behavior(GO:0042755) |
0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 1.1 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.2 | 1.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 2.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.5 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 2.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 2.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.9 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.3 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.2 | 3.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 3.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 1.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.2 | 0.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 1.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 1.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.2 | 0.8 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) peptidyl-glutamine modification(GO:0018199) isopeptide cross-linking(GO:0018262) |
0.2 | 0.7 | GO:0051271 | negative regulation of cellular component movement(GO:0051271) |
0.2 | 0.8 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.2 | 0.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.5 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 0.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 1.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.5 | GO:0051208 | sequestering of calcium ion(GO:0051208) regulation of sequestering of calcium ion(GO:0051282) |
0.2 | 0.5 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
0.2 | 0.3 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.7 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.2 | 0.5 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.2 | 0.5 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 2.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.8 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 4.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.3 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.2 | 0.5 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 1.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 0.5 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.2 | 0.5 | GO:1904603 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.2 | 1.0 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.2 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 3.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 2.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.6 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.2 | 1.3 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 2.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0051664 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
0.2 | 0.3 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.2 | 0.3 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 10.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 1.1 | GO:0007320 | insemination(GO:0007320) |
0.2 | 1.4 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.2 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 1.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 0.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.9 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.2 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.2 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.2 | 1.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 1.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.6 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.2 | 0.5 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
0.2 | 2.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 1.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 4.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 3.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 0.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.2 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.3 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.2 | 1.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.9 | GO:0015853 | adenine transport(GO:0015853) |
0.2 | 0.9 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 1.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 0.8 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 0.2 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.2 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 1.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.7 | GO:0030850 | prostate gland development(GO:0030850) |
0.1 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 1.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 2.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.6 | GO:0051413 | response to cortisone(GO:0051413) |
0.1 | 0.6 | GO:0090493 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.3 | GO:0071870 | response to monoamine(GO:0071867) cellular response to monoamine stimulus(GO:0071868) response to catecholamine(GO:0071869) cellular response to catecholamine stimulus(GO:0071870) |
0.1 | 0.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 2.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.1 | GO:0002708 | positive regulation of lymphocyte mediated immunity(GO:0002708) |
0.1 | 0.3 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.9 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 14.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.4 | GO:1990828 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 2.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 7.1 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.1 | 1.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.4 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 7.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 2.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 1.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 2.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.3 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.1 | 0.4 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 2.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.7 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.5 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.1 | 2.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 5.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 1.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:0051801 | cytolysis by symbiont of host cells(GO:0001897) cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
0.1 | 2.6 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.1 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 2.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 1.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 2.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.3 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.6 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 3.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.1 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.4 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.6 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.1 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.5 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 0.2 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 2.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 1.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 3.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 1.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 1.2 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 1.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 2.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 2.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 1.1 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 1.8 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.7 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 1.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 1.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 2.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.2 | GO:0071657 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.1 | 3.4 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.3 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.8 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.5 | GO:0070627 | ferrous iron import(GO:0070627) |
0.1 | 7.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 1.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 0.6 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 0.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 1.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 4.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.2 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 3.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.1 | 0.2 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.1 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 1.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 1.2 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.1 | 0.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.1 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 5.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.3 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.1 | 0.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 1.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.7 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.4 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.9 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 1.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 1.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 0.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 1.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.3 | GO:0032196 | transposition(GO:0032196) |
0.1 | 1.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.1 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.2 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.5 | GO:2000328 | peptidyl-lysine oxidation(GO:0018057) regulation of T-helper 17 cell lineage commitment(GO:2000328) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.1 | 0.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:1901374 | acetate ester transport(GO:1901374) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 1.5 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 1.9 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.4 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 0.3 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.6 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
0.1 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.2 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.3 | GO:0040008 | regulation of growth(GO:0040008) |
0.1 | 0.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 1.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.3 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.1 | 0.3 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
0.1 | 0.8 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 2.9 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 1.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.1 | 9.9 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 0.3 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.1 | 0.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.1 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.1 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.5 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 2.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.1 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.4 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 1.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.6 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 2.5 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 5.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 0.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 5.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.9 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 2.3 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.2 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 2.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.1 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 1.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.2 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.7 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 2.8 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.2 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.2 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.1 | 0.8 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.2 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 0.2 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.1 | 0.8 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 9.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 2.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 1.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.1 | 0.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.1 | 5.3 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
0.1 | 1.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.1 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.7 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.3 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.2 | GO:0031446 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) maintenance of mitochondrion location(GO:0051659) |
0.1 | 2.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 1.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 1.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.6 | GO:0007129 | synapsis(GO:0007129) |
0.1 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.3 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 1.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 2.2 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.5 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.1 | 0.6 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.4 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 2.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 2.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.1 | 0.1 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 1.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.4 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.1 | 1.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.4 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.1 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
0.1 | 0.1 | GO:0007623 | circadian rhythm(GO:0007623) |
0.1 | 0.1 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.1 | GO:0000725 | recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.3 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.9 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 4.4 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.1 | 0.2 | GO:0070839 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.1 | 1.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.1 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.3 | GO:0010469 | regulation of receptor activity(GO:0010469) |
0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.2 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 4.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.5 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.3 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0044246 | regulation of multicellular organismal metabolic process(GO:0044246) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.8 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.1 | 0.8 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 2.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.2 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
0.1 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.6 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.3 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 0.2 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 0.3 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 4.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 1.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.2 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.1 | 0.2 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.1 | 0.1 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.1 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.5 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.2 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.0 | 0.3 | GO:0030335 | positive regulation of cell migration(GO:0030335) |
0.0 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.1 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 1.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.6 | GO:0043066 | negative regulation of apoptotic process(GO:0043066) |
0.0 | 0.1 | GO:0002606 | positive regulation of antigen processing and presentation(GO:0002579) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.3 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.2 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.9 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.1 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 2.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.2 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.3 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.3 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 2.5 | GO:0098869 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.4 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.0 | 0.3 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.1 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.0 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 2.0 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.0 | 1.6 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.5 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.3 | GO:0071599 | otic vesicle development(GO:0071599) |
0.0 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.0 | 0.2 | GO:0030111 | regulation of Wnt signaling pathway(GO:0030111) |
0.0 | 0.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.7 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.0 | 0.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.3 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.5 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.4 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.4 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 1.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 1.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.0 | 0.0 | GO:0055083 | monovalent inorganic anion homeostasis(GO:0055083) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.0 | 0.1 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
0.0 | 0.3 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.0 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 1.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0042245 | RNA repair(GO:0042245) |
0.0 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.3 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.3 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.0 | 0.1 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) regulation of hair follicle development(GO:0051797) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 1.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 3.6 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 1.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.0 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
0.0 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.0 | 0.1 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.0 | 1.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.1 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.1 | GO:0046219 | indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.0 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.2 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.3 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.0 | 0.2 | GO:1901380 | negative regulation of potassium ion transmembrane transport(GO:1901380) |
0.0 | 0.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 1.9 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.4 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.4 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.4 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.0 | 0.0 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
0.0 | 0.1 | GO:0021551 | central nervous system morphogenesis(GO:0021551) |
0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.3 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.4 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.2 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.0 | 0.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.1 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.9 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.1 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.0 | 0.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.3 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.0 | 0.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:1901673 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.0 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.0 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
1.2 | 1.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.1 | 3.3 | GO:0075341 | host cell PML body(GO:0075341) |
1.1 | 3.2 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
1.0 | 6.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.9 | 2.8 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.9 | 7.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.9 | 6.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.8 | 3.4 | GO:0070985 | TFIIK complex(GO:0070985) |
0.8 | 9.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.8 | 2.4 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.8 | 3.9 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.8 | 4.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.7 | 1.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.7 | 8.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.7 | 2.2 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.7 | 2.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.7 | 4.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 0.7 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.7 | 2.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.7 | 8.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.7 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.7 | 4.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.7 | 1.3 | GO:0044753 | amphisome(GO:0044753) |
0.7 | 2.0 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.7 | 4.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.6 | 3.2 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 3.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 3.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.6 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 0.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.6 | 2.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 1.7 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.6 | 4.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 1.7 | GO:0034455 | t-UTP complex(GO:0034455) |
0.6 | 4.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.6 | 1.7 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.6 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 3.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 0.6 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.6 | 4.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 2.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 2.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 0.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 0.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.5 | 4.8 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.5 | 2.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.5 | 2.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.5 | 4.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.5 | 8.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
0.5 | 2.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.5 | 1.5 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.5 | 0.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.5 | 9.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.5 | 3.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.5 | 7.9 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 2.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 1.5 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.5 | 3.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.5 | 4.8 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 6.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.5 | 2.8 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.5 | 4.7 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.5 | 3.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 2.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.3 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.4 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.4 | 2.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.4 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 4.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.4 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 1.7 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.4 | 1.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.4 | 5.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 7.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 1.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 2.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.4 | 3.2 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 2.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 8.1 | GO:0097227 | sperm annulus(GO:0097227) |
0.4 | 1.6 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.4 | 2.8 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.4 | 3.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 3.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 2.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.4 | 1.9 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.4 | 3.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 0.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.4 | 1.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 4.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 2.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 11.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 2.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 4.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 1.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.4 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 5.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 3.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 3.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 9.6 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.3 | 3.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 5.4 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 1.3 | GO:0043291 | RAVE complex(GO:0043291) |
0.3 | 2.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.6 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.0 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.3 | 2.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 7.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 7.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.3 | 0.9 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 5.3 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 1.8 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 3.0 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 3.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 2.4 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.5 | GO:0070701 | mucus layer(GO:0070701) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 0.3 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.3 | 5.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 5.3 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.3 | 2.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.3 | 1.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 1.1 | GO:0031213 | RSF complex(GO:0031213) |
0.3 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
0.3 | 3.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 1.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.3 | 9.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 6.5 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 3.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 6.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 2.4 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 0.8 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.3 | 3.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.3 | 2.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 0.3 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.3 | 2.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.3 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 2.1 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 1.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 3.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.3 | 2.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 4.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 4.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 2.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 4.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 3.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.0 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 0.7 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.2 | 5.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 1.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 3.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 3.8 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 1.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.9 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 2.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 0.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 0.9 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.2 | 0.4 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.2 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.9 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 2.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.7 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.2 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 6.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.9 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.2 | 1.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 1.1 | GO:0032300 | mismatch repair complex(GO:0032300) MutLalpha complex(GO:0032389) |
0.2 | 2.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.0 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.2 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 9.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 2.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.6 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 0.6 | GO:0008623 | CHRAC(GO:0008623) |
0.2 | 0.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 3.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 2.3 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 7.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 3.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.8 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 4.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.8 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 1.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 4.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.5 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.2 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 1.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 0.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 4.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 3.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
0.2 | 2.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 2.6 | GO:0001741 | XY body(GO:0001741) |
0.2 | 5.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 1.5 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
0.2 | 1.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.2 | 0.7 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 2.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 5.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.3 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.2 | 0.7 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 4.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 1.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 2.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.5 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.2 | 0.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.2 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.5 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.2 | 2.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.3 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.2 | 1.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 3.2 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 2.1 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 2.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.8 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.2 | 1.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 1.2 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.2 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 5.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 3.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.9 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 1.8 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.4 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 3.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 1.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 9.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 2.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 3.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 2.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 3.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 3.5 | GO:0031091 | platelet alpha granule(GO:0031091) platelet alpha granule lumen(GO:0031093) |
0.1 | 0.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 1.9 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 2.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 2.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 4.6 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 3.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 3.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.4 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 3.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 6.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 3.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 6.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 2.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 1.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 3.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.6 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.1 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.9 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 4.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.7 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 3.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 4.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 2.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.1 | 8.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 1.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 4.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.3 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 6.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 11.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 5.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 12.5 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 2.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 11.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 2.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 5.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 2.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 1.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.1 | 4.2 | GO:0015935 | small ribosomal subunit(GO:0015935) cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 6.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.2 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 3.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 5.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.8 | GO:0000803 | sex chromosome(GO:0000803) sex chromatin(GO:0001739) |
0.1 | 2.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 2.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 3.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 3.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 11.4 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 2.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 4.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.9 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.4 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 12.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 9.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.1 | 0.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 6.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 3.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 11.6 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 7.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 6.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 1.9 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) |
0.1 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 2.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 2.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 2.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 1.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.1 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.1 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.3 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 31.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.9 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.7 | GO:0031513 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 5.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 0.0 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 4.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 2.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 5.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 6.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 3.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 2.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 3.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.2 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 2.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 32.1 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 14.3 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.7 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 3.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 1.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.2 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.1 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.0 | 0.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 1.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 1.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 19.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 2.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.2 | GO:0097060 | synaptic membrane(GO:0097060) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 9.9 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.9 | 5.8 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
1.6 | 4.9 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
1.5 | 1.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.5 | 17.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.4 | 5.5 | GO:0003896 | DNA primase activity(GO:0003896) |
1.3 | 5.1 | GO:0032427 | GBD domain binding(GO:0032427) |
1.2 | 5.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
1.1 | 7.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.0 | 5.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
1.0 | 5.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
1.0 | 8.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.0 | 12.6 | GO:0031386 | protein tag(GO:0031386) |
1.0 | 5.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
1.0 | 5.7 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.9 | 3.8 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.9 | 2.8 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
0.9 | 3.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.9 | 2.7 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.9 | 2.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.9 | 3.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 2.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 0.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.8 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.8 | 8.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 3.3 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.8 | 3.2 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.8 | 4.0 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.8 | 3.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.8 | 3.9 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.8 | 0.8 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.8 | 3.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 3.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.7 | 3.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.7 | 2.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 4.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.7 | 2.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.7 | 2.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 0.7 | GO:0032181 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide insertion or deletion binding(GO:0032139) dinucleotide repeat insertion binding(GO:0032181) |
0.7 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.7 | 8.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.7 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.7 | 2.0 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.6 | 3.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.6 | 3.9 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.6 | 7.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 2.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 2.5 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.6 | 4.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.6 | 4.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.6 | 1.8 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.6 | 1.8 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.6 | 3.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 1.7 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.6 | 0.6 | GO:0036041 | long-chain fatty acid binding(GO:0036041) icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.6 | 1.7 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.6 | 2.9 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.6 | 5.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 0.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.6 | 6.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 3.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 3.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 0.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.6 | 1.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.6 | 2.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.6 | 1.7 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.6 | 1.7 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.6 | 1.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.6 | 2.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 3.9 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.6 | 2.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.6 | 4.4 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 1.6 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.5 | 0.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.5 | 3.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.5 | 0.5 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 3.8 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.5 | 15.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) snRNA stem-loop binding(GO:0035614) |
0.5 | 2.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.5 | 2.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 2.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.5 | 2.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.5 | 1.6 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.5 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 6.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 2.0 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.5 | 1.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.5 | 4.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 1.5 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.5 | 2.5 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.5 | 1.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 6.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.5 | 3.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 2.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 1.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 3.9 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.5 | 1.5 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.5 | 1.5 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.5 | 1.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 0.5 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.5 | 1.4 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.5 | 5.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 1.4 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.5 | 2.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 3.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.5 | 3.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.5 | 1.9 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.5 | 1.4 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.5 | 4.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.5 | 1.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 1.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 1.4 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.5 | 1.4 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.4 | 4.0 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.4 | 1.8 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.4 | 2.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 6.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.4 | 2.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 1.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.4 | 2.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.4 | 1.7 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 4.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 1.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.4 | 1.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.4 | 3.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 1.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 1.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.4 | 0.4 | GO:0004620 | phospholipase activity(GO:0004620) |
0.4 | 11.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 1.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 4.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 6.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 2.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.4 | 5.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.4 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 2.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.4 | 3.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 1.2 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.4 | 1.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 9.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 1.2 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.4 | 1.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.4 | 1.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.4 | 2.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 1.2 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.4 | 1.5 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.4 | 1.1 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.4 | 4.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.1 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.4 | 1.1 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.4 | 1.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 4.2 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 0.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 0.4 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.4 | 2.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 7.5 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 1.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.4 | 1.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.4 | 0.7 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.4 | 0.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 3.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.1 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.4 | 2.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.4 | 3.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 2.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.4 | 3.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 0.7 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.4 | 3.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.1 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
0.4 | 1.1 | GO:0072545 | tyrosine binding(GO:0072545) |
0.4 | 1.4 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.4 | 4.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.1 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) ghrelin receptor binding(GO:0031768) |
0.4 | 1.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.4 | 1.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.4 | 2.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 15.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 2.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 2.8 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 2.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 1.0 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.3 | 1.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 2.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 9.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 1.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 1.0 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.3 | 2.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 0.7 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.3 | 1.7 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.3 | 1.0 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 1.0 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.3 | 1.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 0.7 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.3 | 3.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 1.0 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.3 | 1.6 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.3 | 4.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 1.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.3 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 1.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 1.6 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.3 | 1.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 3.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 2.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 1.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 0.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 1.6 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.3 | 0.9 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.3 | 2.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 5.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 1.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 1.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.3 | 0.3 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.3 | 3.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 4.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.3 | 2.4 | GO:0098639 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 1.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.2 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.3 | 9.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 0.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 2.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 3.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 0.9 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.3 | 2.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.3 | 2.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 2.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 7.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 0.9 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.3 | 0.9 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.3 | 1.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 0.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 1.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.3 | 2.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 4.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 2.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 2.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 2.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 2.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 3.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.8 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.3 | 1.7 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.3 | 8.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 1.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 1.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 5.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 0.8 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.3 | 1.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.3 | 3.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.1 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.3 | 2.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.3 | 1.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 1.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 6.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 2.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 0.8 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
0.3 | 5.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 1.1 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.3 | 5.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 1.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.3 | 0.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 0.5 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.3 | 1.8 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.3 | 4.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 2.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 1.8 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.2 | 1.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.7 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.2 | 0.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 2.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 3.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.7 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.2 | 0.5 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.2 | 0.7 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 6.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.7 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.2 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 2.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 3.1 | GO:0097617 | annealing activity(GO:0097617) |
0.2 | 0.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.9 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 2.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 2.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 3.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 5.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.7 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.2 | 3.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.9 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 5.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 16.6 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.2 | 0.7 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.2 | 2.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.2 | 2.0 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 2.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.2 | 4.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 1.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 10.8 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 1.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 1.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.6 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.2 | 7.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 3.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 1.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 0.6 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.2 | 1.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.8 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.2 | 2.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.4 | GO:0004803 | transposase activity(GO:0004803) |
0.2 | 1.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 1.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.8 | GO:0004663 | protein geranylgeranyltransferase activity(GO:0004661) Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.8 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 6.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 1.2 | GO:1902444 | riboflavin binding(GO:1902444) |
0.2 | 1.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 2.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 3.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.2 | 0.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.2 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 5.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 9.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 2.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 3.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.6 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.2 | 1.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 1.0 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.2 | 2.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 2.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.9 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 2.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 3.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 0.7 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.2 | 1.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 4.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 2.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 3.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
0.2 | 5.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.7 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.2 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.6 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 2.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 0.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 1.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 2.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 7.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 3.6 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 2.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 0.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.2 | 0.2 | GO:0000035 | acyl binding(GO:0000035) |
0.2 | 0.7 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.2 | 6.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 3.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 4.4 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 2.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.5 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.2 | 0.5 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.2 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 7.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.5 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.2 | 0.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.2 | 0.5 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.2 | 0.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 3.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 1.3 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 2.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.5 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.2 | 1.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 2.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 2.0 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.3 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.2 | 1.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.9 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.4 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 4.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 2.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 1.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 7.1 | GO:0005501 | retinoid binding(GO:0005501) |
0.1 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 4.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 1.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 7.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.6 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 4.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 1.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 1.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.7 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 5.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.8 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 2.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.9 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.1 | 2.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 2.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 2.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 1.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 9.8 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 2.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.4 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.1 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 15.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.4 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.5 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 0.2 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 3.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 2.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.6 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 1.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.2 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.1 | 1.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.4 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.1 | 0.4 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 0.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 2.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.4 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.5 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
0.1 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 6.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.1 | 1.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0043295 | glutathione binding(GO:0043295) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.9 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.8 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.6 | GO:0016934 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.3 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 0.7 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.4 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 1.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.4 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 1.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 1.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 2.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 4.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.1 | 0.3 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.8 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.1 | GO:0097367 | carbohydrate derivative binding(GO:0097367) |
0.1 | 0.1 | GO:0015211 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleoside transmembrane transporter activity(GO:0015211) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.1 | 0.4 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 1.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.3 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.1 | 3.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 1.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 12.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 3.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 1.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 2.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 0.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.3 | GO:0030109 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) inhibitory MHC class I receptor activity(GO:0032396) |
0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.3 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.7 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 4.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.1 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.1 | 1.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 7.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 4.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.2 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.1 | 1.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 2.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 11.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 0.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 4.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 25.3 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 2.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 1.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.8 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0016247 | channel regulator activity(GO:0016247) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 5.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 7.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:1990175 | EH domain binding(GO:1990175) |
0.1 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 3.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 2.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 2.3 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.7 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 3.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 3.6 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 5.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 2.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 3.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 5.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.3 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.1 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 14.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.1 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 0.2 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 2.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.1 | 0.2 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.1 | 0.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.1 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 1.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 2.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 1.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 5.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 1.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.0 | 1.0 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.0 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.0 | 0.2 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.0 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.0 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 6.7 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 1.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 1.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 10.3 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0030395 | lactose binding(GO:0030395) |
0.0 | 0.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 1.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.3 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 1.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.6 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.0 | 3.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.2 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 1.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 4.9 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 1.4 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 1.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 1.9 | GO:0004672 | protein kinase activity(GO:0004672) |
0.0 | 0.1 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.0 | 2.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.0 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.0 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.0 | 6.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 2.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.0 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 1.9 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 9.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 3.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 1.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 3.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 10.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 6.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 2.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 16.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 22.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 5.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 13.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 6.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 5.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 7.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 6.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 9.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 6.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 3.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 14.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 7.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 4.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 4.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 5.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 5.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 7.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 8.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 9.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 4.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 4.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 23.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.6 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 11.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 3.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 3.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 4.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 7.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 3.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 12.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 1.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 3.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 9.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.0 | 14.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.9 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 68.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 3.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 6.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.5 | 3.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 7.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 2.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 0.9 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.4 | 0.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 14.7 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.4 | 5.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 5.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 11.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 7.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.4 | 4.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 6.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 9.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 8.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 7.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 2.6 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 7.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 1.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 10.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 6.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 9.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 4.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 7.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 11.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 16.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 8.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 3.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 3.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 3.5 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 4.7 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.2 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 1.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 5.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 6.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 4.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 36.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 7.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 6.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 11.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 3.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 4.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 1.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 4.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 6.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 6.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 3.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 1.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 4.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 13.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 5.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 3.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 6.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 29.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 7.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 5.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 4.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 6.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 13.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 3.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 1.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 4.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.2 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.2 | 0.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 2.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 2.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 6.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 6.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 3.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 4.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 5.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 6.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.0 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.8 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 2.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 5.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 5.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 2.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 3.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 4.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.9 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 3.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 22.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 4.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 2.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 3.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 5.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 3.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 4.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 3.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 4.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 6.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 7.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 5.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 3.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 3.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 2.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 1.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 2.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 1.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 1.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 1.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 7.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 15.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 3.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 3.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 2.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 2.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |